OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2.

Manual senior Davis Randle was able to finally join his Crimson teammates on the court Wednesday night after battling cancer. Randle was diagnosed with Osteosarcoma in December 2023, after ...